- Supported exchanges /
- TWO /
- 6461.TWO
Intech Biopharm Ltd (6461 TWO) stock market data APIs
Intech Biopharm Corporation engages in developing and manufacturing generic drugs to treat respiratory diseases in Taiwan and internationally. It owns iLEF (inhaled low ethanol formulation), a metered dose inhaler platform for treating asthma and COPD; and dry powder inhaler, a product comprises of blisters and capsules. The company offers its products under the SYN006, SYN010, SYN007, Synflutide, Duasma, Synvent, and SYN011 names. Intech Biopharm Corporation was founded in 2010 and is headquartered in Taipei, Taiwan.
Intech Biopharm Ltd Financial Data Overview
| 29 | |
| 29.45 | |
| - | |
| 29.5 | |
| 28.7 | |
| 23.6-34.6 | |
| 3 985 M | |
| 137 M | |
| 32 278 K | |
| -0.6957 | |
| 0.319 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Intech Biopharm Ltd Fundamental Data is available in our Financial Data APIs
- Net Revenue 32 278 K
- EBITDA -249 828 992
- Earnings Per Share -2.71
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Intech Biopharm Ltd Earnings via APIs
- Latest Release 2023-05-31
- EPS/Forecast NaN
Get Intech Biopharm Ltd End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
